Exciting news for people living with idiopathic pulmonary fibrosis (IPF). Two large clinical trials TETON-1 and TETON-2 showed that an inhaled medication called treprostinil (Tyvaso) slows the loss of lung function in patient with … [Read more...]
Jeremy Feldman, MD
Exciting news for people living with idiopathic pulmonary fibrosis (IPF). Two large clinical trials TETON-1 and TETON-2 showed that an inhaled medication called treprostinil (Tyvaso) slows the loss of lung function in patient with … [Read more...]